Xizang Haisco Pharmaceutical Group Co Ltd (002653) — Tangible Net Worth Ratio
Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Tangible Net Worth Ratio of 49.0% as of March 2026. This metric is calculated by deducting intangible assets (CN¥2.47 Billion) from net assets (CN¥4.84 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 002653 book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Xizang Haisco Pharmaceutical Group Co Ltd Tangible Net Worth Ratio (2008–2025)
This chart shows how Xizang Haisco Pharmaceutical Group Co Ltd's Tangible Net Worth Ratio has changed across 18 annual periods from 2008 to 2025. As of March 2026, the ratio stands at 49.0%, reflecting net assets of CN¥4.84 Billion with intangible assets of CN¥2.47 Billion CNY. Also explore 002653 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2025, covering 18 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Xizang Haisco Pharmaceutical Group Co Lt (002653) total market value.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 42.4% | CN¥4.29 Billion | CN¥2.47 Billion | CN¥7.01 Billion | ▼ -0.9 pp |
| 2024 | 43.4% | CN¥4.20 Billion | CN¥2.38 Billion | CN¥6.80 Billion | ▼ -4.5 pp |
| 2023 | 47.8% | CN¥4.17 Billion | CN¥2.18 Billion | CN¥6.65 Billion | ▲ +9.7 pp |
| 2022 | 38.1% | CN¥3.13 Billion | CN¥1.94 Billion | CN¥6.05 Billion | ▼ -10.5 pp |
| 2021 | 48.6% | CN¥2.92 Billion | CN¥1.50 Billion | CN¥5.01 Billion | ▼ -9.9 pp |
| 2020 | 58.5% | CN¥2.85 Billion | CN¥1.18 Billion | CN¥5.00 Billion | ▼ -1.0 pp |
| 2019 | 59.5% | CN¥2.38 Billion | CN¥961.39 Million | CN¥5.04 Billion | ▼ -9.2 pp |
| 2018 | 68.7% | CN¥1.99 Billion | CN¥623.98 Million | CN¥4.37 Billion | ▼ -6.2 pp |
| 2017 | 74.9% | CN¥1.97 Billion | CN¥494.39 Million | CN¥4.11 Billion | ▼ -9.4 pp |
| 2016 | 84.3% | CN¥2.25 Billion | CN¥351.48 Million | CN¥3.74 Billion | ▼ -1.9 pp |
| 2015 | 86.3% | CN¥2.16 Billion | CN¥295.71 Million | CN¥3.23 Billion | ▼ -7.7 pp |
| 2014 | 94.0% | CN¥2.11 Billion | CN¥125.87 Million | CN¥2.87 Billion | ▼ -1.6 pp |
| 2013 | 95.6% | CN¥1.93 Billion | CN¥84.04 Million | CN¥2.46 Billion | ▼ -2.2 pp |
| 2012 | 97.8% | CN¥1.71 Billion | CN¥37.71 Million | CN¥1.95 Billion | ▲ +3.9 pp |
| 2011 | 93.9% | CN¥767.76 Million | CN¥46.87 Million | CN¥882.70 Million | ▲ +0.7 pp |
| 2010 | 93.2% | CN¥453.09 Million | CN¥30.77 Million | CN¥629.88 Million | ▲ +2.8 pp |
| 2009 | 90.4% | CN¥135.17 Million | CN¥12.99 Million | CN¥349.39 Million | ▼ -3.7 pp |
| 2008 | 94.1% | CN¥214.95 Million | CN¥12.71 Million | CN¥353.69 Million | — |